세계의 척수강내 펌프 시장

Global Intrathecal Pumps Market to Reach US$369.9 Million by 2030

The global market for Intrathecal Pumps estimated at US$262.5 Million in the year 2023, is expected to reach US$369.9 Million by 2030, growing at a CAGR of 5.0% over the analysis period 2023-2030. Morphine, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$115.9 Million by the end of the analysis period. Growth in the Ziconotide segment is estimated at 5.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$71.4 Million While China is Forecast to Grow at 4.8% CAGR

The Intrathecal Pumps market in the U.S. is estimated at US$71.4 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$58.8 Million by the year 2030 trailing a CAGR of 4.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.6% and 4.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.0% CAGR.

Global Intrathecal Pumps Market - Key Trends & Drivers Summarized

What Are Intrathecal Pumps and Why Are They Critical for Chronic Pain and Spasticity Management?

Intrathecal pumps are medical devices used to deliver medications directly into the spinal fluid, offering targeted pain relief and management of spasticity in patients with chronic conditions. These pumps are critical in managing severe, intractable pain and spasticity that do not respond well to oral medications or other treatments. By delivering medication directly to the central nervous system, intrathecal pumps allow for lower dosages and reduced systemic side effects compared to traditional pain management methods. They are particularly beneficial for patients with conditions such as cancer pain, failed back surgery syndrome, and multiple sclerosis. As the prevalence of chronic pain and neurological disorders continues to rise, intrathecal pumps are becoming increasingly vital in providing effective and sustained relief for these patients.

How Are Technological Advancements Shaping the Intrathecal Pumps Market?

Technological advancements are significantly shaping the intrathecal pumps market, particularly through innovations in pump design, drug delivery precision, and patient monitoring. Modern intrathecal pumps are now more compact, programmable, and capable of delivering precise doses tailored to the individual needs of patients. Advances in battery technology have extended the lifespan of these devices, reducing the need for frequent replacements or recharging. Additionally, the integration of wireless communication and remote monitoring capabilities is allowing healthcare providers to adjust pump settings and monitor patient progress in real-time, enhancing the overall effectiveness and safety of pain and spasticity management. These innovations are driving the adoption of intrathecal pumps as a preferred option for long-term management of chronic conditions, offering patients a higher quality of life.

Why Is There an Increasing Demand for Intrathecal Pumps in Pain Management and Neurology?

The demand for intrathecal pumps is increasing in pain management and neurology due to the growing incidence of chronic pain, the aging population, and the limitations of traditional pain relief methods. As more patients seek effective, long-term solutions for managing severe pain and spasticity, intrathecal pumps are emerging as a critical option, particularly for those who have not found relief through conventional treatments. The aging global population is also contributing to the demand, as older adults are more likely to suffer from chronic conditions that require intensive pain management. Furthermore, the opioid crisis has highlighted the need for alternative pain management strategies, leading to a greater emphasis on intrathecal drug delivery as a safer and more effective option. As awareness of the benefits of intrathecal pumps continues to grow among healthcare providers and patients, the market is expected to expand.

What Factors Are Driving the Growth in the Intrathecal Pumps Market?

The growth in the intrathecal pumps market is driven by several factors related to technological advancements, the increasing prevalence of chronic pain and neurological disorders, and the growing demand for alternative pain management solutions. One of the primary drivers is the advancement in pump technology, which has improved the precision, safety, and ease of use of these devices. The rising incidence of chronic conditions that cause severe pain and spasticity, such as cancer and multiple sclerosis, is also fueling demand for intrathecal pumps, as these conditions often require long-term, targeted treatment. The growing awareness of the risks associated with systemic pain medications, particularly opioids, is encouraging the adoption of intrathecal pumps as a safer and more effective alternative. Additionally, the increasing investment in healthcare infrastructure and the expansion of pain management clinics are contributing to market growth, as more patients gain access to advanced treatments. As these trends continue to evolve, the intrathecal pumps market is expected to experience sustained growth, driven by the need for innovative, effective, and patient-centric pain management solutions.

Select Competitors (Total 42 Featured) -

• Advance Neuromodulation System
• Advanced Bionics
• Arrow International
• Baxter
• Boston Scientific
• Codman & Shurtleff
• DJO Global
• Dynacast
• Flowonix Medical
• Inteprod
• Johnson and Johnson Services, Inc.
• Medallion Therapeutics
• Medasys
• Medtronic plc
• Perlong Medical Equipment
• Qinhuangdao Sanwin Trading
• Smiths Medical
• St. Jude Medical
• Stryker
• Teleflex
• Tricumed

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Intrathecal Pumps - Global Key Competitors Percentage Market Share in 2024 (E)
  • Global Economic Update
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Growing Demand for Pain Management Solutions Spurs Adoption of Intrathecal Pumps
  • Advancements in Pump Technology Propel Innovation in Intrathecal Drug Delivery
  • Shift Towards Minimally Invasive Pain Management Expands Market Opportunities
  • Increasing Use of Intrathecal Pumps in Treating Chronic Pain and Spasticity
  • Role of Intrathecal Pumps in Reducing Opioid Consumption
  • Growing Importance of Personalized Pain Management Solutions
  • Advancements in Implantable Devices Propel Market Growth
  • Emerging Markets Present New Opportunities for Intrathecal Pump Manufacturers
  • Push for Cost-Effective and Long-Term Pain Relief Solutions
  • Role of Intrathecal Pumps in Enhancing Quality of Life for Patients with Severe Pain
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Intrathecal Pumps Market Analysis of Annual Sales in US$ for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Intrathecal Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Intrathecal Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 4: World 16-Year Perspective for Intrathecal Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Morphine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Morphine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 7: World 16-Year Perspective for Morphine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Ziconotide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Ziconotide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 10: World 16-Year Perspective for Ziconotide by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Baclofen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Baclofen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 13: World 16-Year Perspective for Baclofen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Bupivacaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Bupivacaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 16: World 16-Year Perspective for Bupivacaine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Clonidine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Clonidine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 19: World 16-Year Perspective for Clonidine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 22: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 25: World 16-Year Perspective for Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Spasticity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Spasticity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 28: World 16-Year Perspective for Spasticity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
  • TABLE 29: USA Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 30: USA Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 31: USA 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
  • TABLE 32: USA Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 33: USA Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 34: USA 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
• CANADA
  • TABLE 35: Canada Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 36: Canada Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 37: Canada 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
  • TABLE 38: Canada Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 39: Canada Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 40: Canada 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
• JAPAN
  • Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
  • TABLE 41: Japan Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 42: Japan Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 43: Japan 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
  • TABLE 44: Japan Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 45: Japan Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 46: Japan 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
• CHINA
  • Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
  • TABLE 47: China Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 48: China Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 49: China 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
  • TABLE 50: China Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 51: China Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 52: China 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
• EUROPE
  • Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
  • TABLE 53: Europe Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 54: Europe Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 55: Europe 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
  • TABLE 56: Europe Recent Past, Current & Future Analysis for Intrathecal Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
  • TABLE 57: Europe Historic Review for Intrathecal Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 58: Europe 16-Year Perspective for Intrathecal Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
  • TABLE 59: Europe Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 60: Europe Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 61: Europe 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
• FRANCE
  • Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
  • TABLE 62: France Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 63: France Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 64: France 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
  • TABLE 65: France Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 66: France Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 67: France 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
• GERMANY
  • Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
  • TABLE 68: Germany Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 69: Germany Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 70: Germany 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
  • TABLE 71: Germany Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 72: Germany Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 73: Germany 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
• ITALY
  • TABLE 74: Italy Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 75: Italy Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 76: Italy 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
  • TABLE 77: Italy Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 78: Italy Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 79: Italy 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
• UNITED KINGDOM
  • Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
  • TABLE 80: UK Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 81: UK Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 82: UK 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
  • TABLE 83: UK Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 84: UK Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 85: UK 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
• REST OF EUROPE
  • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 87: Rest of Europe Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 88: Rest of Europe 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
  • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 90: Rest of Europe Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 91: Rest of Europe 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
• ASIA-PACIFIC
  • Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
  • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 93: Asia-Pacific Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 94: Asia-Pacific 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
  • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 96: Asia-Pacific Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 97: Asia-Pacific 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
• REST OF WORLD
  • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 99: Rest of World Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 100: Rest of World 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
  • TABLE 101: Rest of World Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
  • TABLE 102: Rest of World Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
  • TABLE 103: Rest of World 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030

IV. COMPETITION